Collagen Solutions PLC Allotment of shares and total voting rights (8398V)

TIDMCOS

RNS Number : 8398V

Collagen Solutions PLC

12 August 2020

Collagen Solutions plc

(the "Company")

Allotment of shares to employee benefit trust and Total Voting Rights

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that, on 11 August 2020 it allotted 3,195,929 new ordinary shares of GBP0.01 each in the Company ("New Ordinary Shares") to the trustee of the Collagen Solutions plc Employee Benefit Trust (the "Trust") in order to allow the Trust to satisfy awards previously made under the Collagen Solutions plc Deferred Bonus Plan as previously announced on 3 October 2019.

It is anticipated that the New Ordinary Shares (which will rank pari passu in all respects with the existing ordinary shares of the Company) will be admitted to trading on AIM on or around 17 August 2020 ("Admission"). Following Admission, the Company's issued share capital will comprise 446,878,910 ordinary shares with voting rights and that figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules. The Company does not hold any shares in treasury.

For further information please contact:

 
 Collagen Solutions Plc 
 Jamal Rushdy, CEO 
 Hilary Spence, CFO                                                           Via Walbrook 
 
 Cenkos Securities Plc (Nominated 
  Adviser and Broker) 
 Giles Balleny (Corporate Finance)                                      Tel: 0207 397 8900 
 Stephen Keys 
 
 Walbrook PR Ltd                             Tel: 020 7933 8780 or collagen@walbrookpr.com 
 Anna Dunphy                                                            Mob: 07876 741 001

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCEAKPFFAKEEFA

(END) Dow Jones Newswires

August 12, 2020 02:00 ET (06:00 GMT)

Collagen Solutions (LSE:COS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024